Tuberculosis trials in Peru

In Peru 8 Also abroad 198

8 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Not yet taking people in Peru
Re-evaluating the Duration in Children of TB Treatment
Where
Lima
Age
3 months to 9 years
People
230
Run by
University of Wisconsin, Madison
See details and how to joinNCT07656012
Phase 3Taking people
A Study of Quabodepistat-containing Regimens for the Treatment of Drug-resistant Pulmonary Tuberculosis
Where
La Molina, Lima, Villa El Salvador
Age
14 years and over
People
532 worldwide
Run by
Otsuka Pharmaceutical Development & Commercialization, Inc.
See details and how to joinNCT07209761
Phase 2/3Taking people
Bedaquiline Roll-out Evidence in Contacts and People Living With HIV to Prevent TB
Where
Lima
People
2,530 worldwide
Run by
Johns Hopkins University
See details and how to joinNCT06568484
No phaseTaking people
Bioneer Q-RFIA Clinical Evaluation
Where
Lima
Age
18 years and over
People
2,350 worldwide
Run by
Foundation for Innovative New Diagnostics, Switzerland
See details and how to joinNCT05117788
Phase 1Not yet taking people in Peru
A Clinical Study of the HCMV-TB Vaccine Candidate VIR-1778 in Healthy Adults
Where
Iquitos, Lima
Age
18 years to 55 years
People
116
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07818824
Phase 2/3Taking people
Program for Rifampicin-Resistant Disease With Stratified Medicine for Tuberculosis
Where
Lima
Age
14 years and over
People
400 worldwide
Run by
University of California, San Francisco
See details and how to joinNCT06441006
Phase 2Not yet taking people in Peru
A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)
Where
Callao, Lima
Age
13 years and over
People
900 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT07595042
Phase 2Taking people
Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
Where
Lima
Age
15 years and over
People
330 worldwide
Run by
National Institute of Allergy and Infectious Diseases (NIAID)
See details and how to joinNCT05383742